Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG
Clinical trial NCT00061425 · COMPLETED
Trial details
- NCT number
- NCT00061425
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2007-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.